Boston Partners’s Vivos Therapeutics VVOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,138
Closed -$51K 767
2022
Q3
$51K Sell
3,138
-1,828
-37% -$29.7K ﹤0.01% 710
2022
Q2
$160K Sell
4,966
-528
-10% -$17K ﹤0.01% 678
2022
Q1
$368K Buy
5,494
+1,173
+27% +$78.6K ﹤0.01% 639
2021
Q4
$243K Buy
4,321
+2,455
+132% +$138K ﹤0.01% 659
2021
Q3
$188K Buy
+1,866
New +$188K ﹤0.01% 655